Studies showed that silencing SIRT1 inhibited cell proliferation and tumor formation in some human cancer cell lines such as non‐small‐cell lung cancer and breast cancer (Abdolvahabi et al., 2018; Xu et al., 2018). Here, SIRT1 is linked to neoplasm.